From: Bronchoscopy to assess patients with hemoptysis: which is the optimal timing?
Total cohort, n (%) | 486 (100) | |
Age (years), median (IQR) | 67 (53–76) | |
Males, n (%) | 336/486 (69.2%) | |
Hemoptysis severity, n (%) | Mild | 330/486 (67.9%) |
Moderate | 144/486 (29.6%) | |
Severe | 12/486 (2.4%) | |
Life-threatening hemoptysis, n (%) | 20/486 (4.1%) | |
Flexible bronchoscopies, n (%) | 471/486 (96.9%) | |
Flexible bronchoscopies during endotracheal intubation, n (%) | 2/486 (0.4%) | |
Rigid bronchoscopies, n (%) | 13/486 (2.7%) | |
Therapeutic bronchoscopies, n (%) | 99/486 (20.4%) |